Discovery of 7, 4′-dimethoxy-3-hydroxyflavone as a protease-activated receptor 4 antagonist with antithrombotic activity and less bleeding tendency in mice
Authors:
- 22 June 2022
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 202, 115152
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan
- Kaohsiung Medical University (KMU-DK109002-4)
This publication has 65 references indexed in Scilit:
- Synthesis of Indole Derived Protease-Activated Receptor 4 Antagonists and Characterization in Human PlateletsPLOS ONE, 2013
- Use of Natural Products as Chemical Library for Drug Discovery and Network PharmacologyPLOS ONE, 2013
- 12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivityThrombosis and Haemostasis, 2013
- The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3‐kinase pathway in maintaining thrombin‐induced platelet aggregationBritish Journal of Pharmacology, 2010
- Fuscacarpans A–C, new pterocarpans from the stems of Erythrina fuscaFitoterapia, 2010
- Differential effects of quercetin, apigenin and genistein on signalling pathways of protease‐activated receptors PAR1and PAR4in plateletsBritish Journal of Pharmacology, 2009
- Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammationBlood, 2007
- The role of PAR4 in thrombin-induced thromboxane production in human plateletsThrombosis and Haemostasis, 2003
- Platelet activation: assessment and quantificationEuropean Heart Journal, 2001
- An alternative method for the alignment of molecular structures: Maximizing electrostatic and steric overlapTetrahedron Computer Methodology, 1990